Alprostadil and oxygen saturation decreased Patient Reports February 12, 2012
Alprostadil Side Effects Report #5801798-8
Alprostadil side effect was reported by a Physician from JAPAN on June 18, 2008. Female patient, 76 years of age, was diagnosed with procedural hypotension and was treated with Alprostadil. After drug was administered, patient experienced the following side effects: blood pressure decreased, cardiac index decreased, oxygen saturation decreased. Alprostadil dosage: unknown. During the same period patient was treated with NICORDANDIL. Patient recovered.
Alprostadil Side Effects Report #5809569-3
Alprostadil side effect was reported by a Consumer or non-health professional from JAPAN on June 18, 2008. Female patient, 76 years of age, was diagnosed with procedural hypotension and was treated with Alprostadil. After drug was administered, patient experienced the following side effects: blood pressure decreased, cardiac index decreased, oxygen saturation decreased. Alprostadil dosage: unknown. During the same period patient was treated with NICORANDIL. Patient recovered.
Alprostadil Side Effects Report #5811251-3
Alprostadil side effect was reported by a Consumer or non-health professional from JAPAN on June 18, 2008. Female patient, 76 years of age, was diagnosed with procedural hypotension and was treated with Alprostadil. After drug was administered, patient experienced the following side effects: blood pressure decreased, cardiac index decreased, disease complication, lymphoma
, mitral valve disease, oxygen saturation decreased. Alprostadil dosage: unknown. During the same period patient was treated with NICORANDIL. Patient recovered.Alprostadil Side Effects Report #5314147-9
Alprostadil side effect was reported by a Consumer or non-health professional from AUSTRALIA on Apr 16, 2007. Female patient was diagnosed with heart disease congenital and was treated with Alprostadil. After drug was administered, patient experienced the following side effects: convulsion neonatal, infantile apnoeic attack, oxygen saturation decreased. Alprostadil dosage: unknown. Patient recovered.
Alprostadil Side Effects Report #4653542-8
Alprostadil side effect was reported by a Consumer or non-health professional from on Mar 15, 2005. Male patient was diagnosed with heart disease congenital and was treated with Alprostadil. After drug was administered, patient experienced the following side effects: blood ph decreased, interruption of aortic arch, neonatal disorder, oxygen saturation decreased, pulmonary haemorrhage, respiratory rate decreased, respiratory rate increased, shock, tracheal haemorrhage. Alprostadil dosage: unknown. During the same period patient was treated with MIDAZOLAM. Patient recovered.
Alprostadil Side Effects Report #5034730-8
Alprostadil side effect was reported by a Consumer or non-health professional from JAPAN on Apr 06, 2006. Female patient was diagnosed with heart disease congenital and was treated with Alprostadil. After drug was administered, patient experienced the following side effects: apnoea, blood pressure systolic decreased, cardiac failure, gastrointestinal infection, heart rate increased, intestinal ischaemia, intestinal perforation, oxygen saturation decreased, skin irritation. Alprostadil dosage: unknown. During the same period patient was treated with AMINOPHYLLIN, CEFAZOLIN HYDRATE, BICARBONATE IN PLASTIC CONTAINER, MIDAZOLAM, FUROSEMIDE, CHOLINE THEOPHYLLINE, SPIRONOLACTONE, CEFMETAZOLE. Patient was hospitalized. Patient recovered.
Alprostadil Side Effects Report #4804769-3
Alprostadil side effect was reported by a Health Professional from JAPAN on Aug 22, 2005. Male patient, 65 years of age, was diagnosed with arteriosclerosis obliterans and was treated with Alprostadil. After drug was administered, patient experienced the following side effects: blood pressure decreased, cardiac failure, oxygen saturation decreased, pulmonary congestion, pulmonary oedema, upper gastrointestinal haemorrhage, wound infection. Alprostadil dosage: unknown. During the same period patient was treated with AMLOLDIPINE BESILATE, ATORVASTATIN, CANDESARTAN, CEFAZOLIN, SERUM ALBUMIN, CEFDINIR, LOXOPROFEN, REBAMIPIDE. Patient died.
Alprostadil and oxygen saturation decreased 